Abstract
In a 3-week-old male newborn persistent suprasystemic pulmonary hypertension developed after surgical valvulotomy for a critical aortic valve stenosis. Because of a residual transvalvular pressure gradient of 35 mm Hg and postoperative left as well as right ventricular dysfunction, treatment with inhaled nitric oxide (NO) and intravenously infused prostacyclin (PGI2) was attempted. Low-dose inhaled NO and low dose PGI2 corrected severe pulmonary hypertension and led to an increase in cardiac output. Treatment with NO but not PGI2 was accompanied by a rise in PaO2 and systemic blood pressure. Interruption of NO administration led to a rapid increase in pulmonary arterial pressure to suprasystemic levels. With continued i.v. PGI2 and decreasing concentrations of NO, severe pulmonary hypertension resolved after a few days suggesting that a transient endothelial dysfunction was partially responsible for pulmonary vasoconstriction. NO inhalation appears to be an effective new tool in the treatment of severe pulmonary hypertension following cardiac surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- NO:
-
nitrous oxide
- PGI2 :
-
prostacyclin
References
Abman SH, Chatfield BA, Hall SL, Mcmurtry JF (1990) Role of ERDF during transition of pulmonary circulation at birth. Am J Physiol 259: H1921–1927
Celermajer DS, Cullen S, Deanfield JE (1993) Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87: 440–446
Chiodi H, Mohler JG (1985) Effects of exposure of blood hemoglobin to nitric oxide. Environ Res 37: 355–363
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047
Haworth SG, Sauer U, Bühlmeyer K, Reid L (1977) The development of the pulmonary circulation in ventricular septal defect: a quantitative study. Am J Cardiol 40: 781
Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ (1983) Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther 228: 682–690
Ignarro LJ, Buga GM, Wood Ks, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265–9269
Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J biol Chem 26: 14519–14522
Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low dose inhalational nitri oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819–820
Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664–666
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan A, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173–1174
Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818–820
Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM (1993) Inhaled Nitric oxide in congenital heart disease. Circulation 87: 447–453
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WA (1993) Inhaled Nitric Oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
Schranz D, Zepp F, Iversen S, Wippermann C, Huth R, Zimmer B, Jüngst BK, Oelert H (1992) Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Crit Care Med 20: 1243–1249
Schranz D, Kuroczynski W, Jakob H, Hutz R, Baum V, Wippermann CF Jüngst BK, Oelert H (1992) Behandlung der pulmonalen Hypertension nach Korrektur angeborener Herzfehler: Stellenwert von Prostazyklin. Z Herz Thorax Gefäßchir 6: 311–317
Wessel DL, Adatia J, Thompson J, Kulih TJ (1992) Inhaled nitric oxide (NO) for the treatment of pulmonary hypertension before and after cardiopulmonary bypass (CPB). Circulation [Suppl I] 86: 1–776 (A)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schranz, D., Huth, R., Wippermann, C.F. et al. Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass. Eur J Pediatr 152, 793–796 (1993). https://doi.org/10.1007/BF02073372
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02073372